Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DRISDOL | Validus Pharmaceuticals | N-003444 RX | 1982-01-01 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
3 pack family dollar instant hand sanitizers | OTC monograph not final | 2014-11-28 |
a and d | OTC monograph final | 2020-01-07 |
a and d plus e | C200263 | 2024-08-08 |
adult infuvite multiple vitamins | New Drug Application | 2019-05-14 |
ag international | OTC monograph final | 2019-07-23 |
ameriderm | OTC monograph final | 2022-01-13 |
animi-3 with vitamin d | unapproved drug other | 2011-05-23 |
anubis barcelona | OTC monograph final | 2023-09-01 |
apcal | OTC monograph final | 2013-02-21 |
astonea | C200263 | 2024-06-25 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Osteoporosis | D010024 | HP_0000939 | M81.0 | — | — | 1 | 2 | — | 3 |
Postmenopausal osteoporosis | D015663 | EFO_0003854 | — | — | — | 1 | 2 | — | 3 |
Hepatitis c | D006526 | — | B19.2 | — | — | — | 1 | — | 1 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | — | 1 | — | 1 |
Hepatitis | D006505 | HP_0012115 | K75.9 | — | — | — | 1 | — | 1 |
Chronic hepatitis | D006521 | — | K73.9 | — | — | — | 1 | — | 1 |
Hepatitis a | D006506 | EFO_0007305 | B15 | — | — | — | 1 | — | 1 |
Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 1 | — | 1 |
Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | 1 | — | 1 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 1 | — | 1 | — | — | 2 |
Disease | D004194 | EFO_0000408 | R69 | — | — | 1 | — | — | 1 |
Hematologic neoplasms | D019337 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | 1 | — | — | — | 1 |
Esophageal neoplasms | D004938 | — | C15 | — | 1 | — | — | — | 1 |
Adenocarcinoma | D000230 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Ergocalciferol |
INN | ergocalciferol |
Description | Vitamin D2 is a vitamin D supplement and has been isolated from alfalfa. It has a role as a nutraceutical, a bone density conservation agent, a rodenticide and a plant metabolite. It is a seco-ergostane, a hydroxy seco-steroid and a vitamin D. |
Classification | Small molecule |
Drug class | vitamin D analogs |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C |
PDB | — |
CAS-ID | 50-14-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1536 |
ChEBI ID | 28934 |
PubChem CID | 5280793 |
DrugBank | DB00153 |
UNII ID | VS041H42XC (ChemIDplus, GSRS) |